EUVIMEDEUVIMED entdecken
Multizentrische StudieRandomisierte kontrollierte Studie

Ablation Strategies for Repeat Procedures in Atrial Fibrillation Recurrences Despite Durable Pulmonary Vein Isolation: The Prospective Randomized ASTRO AF Multicenter Trial

Boris Schmidt iD, Stefano Bordignon iD, Andreas Metzner, Philipp Sommer iD, Daniel Steven iD, Tilmann Dahme iD, Matthias Busch iD, Roland Richard Tilz iD, David Schaack iD, Andreas Rillig iD, Christian Sohns iD, Arian Sultan iD und 8 weitere

Circulation · 2024

DOI: 10.1161/circulationaha.124.069993 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Circulation, 2024. Verfasst von Boris Schmidt und 19 weiteren Autor:innen. Beteiligte Einrichtung: Cardioangiologisches Centrum Bethanien, Frankfurt, Germany (B.S., S.B., D. Schaack, K.-R.J.C.). Hauptthemen laut MEDLINE: Atrial Fibrillation, Pulmonary Veins, Recurrence, Catheter Ablation. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 26 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Ablation strategies for patients with symptomatic atrial fibrillation and isolated pulmonary veins vary and their effects on arrhythmia recurrence remain unclear. A prospective randomized German multicenter trial sought to compare 2 ablation strategies in this patient cohort. METHODS: Patients with atrial fibrillation despite durable pulmonary vein isolation were randomly assigned at 7 centers to undergo low-voltage area ablation using 3-dimensional mapping and irrigated radiofrequency current ablation (group A) or empirical left atrial appendage isolation (LAAI) using the cryoballoon followed by staged interventional left atrial appendage closure (group B). The primary end point was freedom from atrial tachyarrhythmias between 91 and 365 days after index ablation. The study was powered for superiority of LAAI compared with low-voltage area. RESULTS: Patients (40% women; mean age, 68.8±8 years) with paroxysmal (32%) or persistent atrial fibrillation (68%) were randomized to undergo low-voltage area ablation (n=79) or cryoballoon-guided LAAI (n=82). After a planned interim analysis, enrollment was halted for futility on January 10, 2023. In the LAAI group, 77 of 82 left atrial appendages were successfully isolated with subsequent left atrial appendage closure in 57 patients. Procedure-related complications occurred in 4 (5%) and 11 (13.5%) patients in group A and B, respectively ( P =0.10). The median follow-up was 367 days (interquartile range, 359–378). The Kaplan-Meier point estimate for freedom from atrial tachyarrhythmias was 51.7% (CI, 40.9%–65.4%) for group A and 55.5% (CI, 44.4%–69.2%; P =0.8069) for group B. CONCLUSIONS: The current study did not detect superiority of cryoballoon-guided LAAI over low-voltage area ablation in patients with atrial fibrillation despite durable PVI. REGISTRATION: URL: https://www.clinicaltrials.gov ; Unique identifier: NCT04056390.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Atrial FibrillationPulmonary VeinsRecurrenceCatheter AblationHumansFemaleMaleAgedProspective StudiesMiddle AgedAtrial AppendageTreatment OutcomeCryosurgeryReoperation

Stichwörter der Autor:innen

arrhythmias, cardiacatrial fibrillationpulmonary veins

Autor:innen und Institutionen

  • Cardioangiologisches Centrum Bethanien, Frankfurt, Germany (B.S., S.B., D. Schaack, K.-R.J.C.).
  • Universitätsklinikum Frankfurt, Medizinische Klinik 3-Klinik für Kardiologie, Frankfurt, Germany (B.S.).
  • University Heart and Vascular Center Hamburg (UHZ), Germany (A.M., A.R.).
  • Clinic for Electrophysiology, Herz- und Diabeteszentrum Nordrhein-Westfalen, Ruhr-Universität Bochum, Bad Oeynhausen, Germany (P.S., C.S., T.F.).
  • University Hospital Cologne-Heart Center, Germany (D. Steven, A.S., J.L.).
  • Uniklinik Ulm, Klinik für Innere Medizin II, Ulm, Germany (T.D., K.W.-E., A.P.).

ORCID-Profile: Boris Schmidt, Stefano Bordignon, Philipp Sommer, Daniel Steven, Tilmann Dahme, Matthias Busch, Roland Richard Tilz, David Schaack, Andreas Rillig, Christian Sohns, Arian Sultan, Julia Vogler, Jakob Lueker, K R Julian Chun

Zitieren

APA

Schmidt, B., Bordignon, S., Metzner, A., Sommer, P., Steven, D., Dahme, T., Busch, M., Tilz, R. R., Schaack, D., Rillig, A., Sohns, C., Sultan, A., Weinmann-Emhardt, K., Hummel, A., Vogler, J., Fink, T., Lueker, J., Pott, A., Heeger, C., & Chun, K. R. J. (2024). Ablation Strategies for Repeat Procedures in Atrial Fibrillation Recurrences Despite Durable Pulmonary Vein Isolation: The Prospective Randomized ASTRO AF Multicenter Trial. Circulation. https://doi.org/10.1161/circulationaha.124.069993

Vancouver

Schmidt B, Bordignon S, Metzner A, Sommer P, Steven D, Dahme T, et al. Ablation Strategies for Repeat Procedures in Atrial Fibrillation Recurrences Despite Durable Pulmonary Vein Isolation: The Prospective Randomized ASTRO AF Multicenter Trial. Circulation. 2024. doi:10.1161/circulationaha.124.069993

BibTeX
@article{Schmidt2024,
  author = {Schmidt, Boris and Bordignon, Stefano and Metzner, Andreas and Sommer, Philipp and Steven, Daniel and Dahme, Tilmann and Busch, Matthias and Tilz, Roland Richard and Schaack, David and Rillig, Andreas and Sohns, Christian and Sultan, Arian and Weinmann-Emhardt, Karolina and Hummel, Astrid and Vogler, Julia and Fink, Thomas and Lueker, Jakob and Pott, Alexander and Heeger, Christian and Chun, K R Julian},
  title = {Ablation Strategies for Repeat Procedures in Atrial Fibrillation Recurrences Despite Durable Pulmonary Vein Isolation: The Prospective Randomized ASTRO AF Multicenter Trial},
  journal = {Circulation},
  year = {2024},
  doi = {10.1161/circulationaha.124.069993}
}
Kostenlos starten →